Cervical cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) |
Nima Nasiri (talk | contribs) |
||
Line 27: | Line 27: | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="15" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan=" | ! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
Line 33: | Line 33: | ||
! colspan="12" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ! colspan="12" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam | ||
! colspan=" | ! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Prolonged menstrual bleeding | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Heavy menstrual bleeding | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Heavy menstrual bleeding | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Postcoital bleeding | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Postcoital bleeding | ||
Line 49: | Line 49: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vaginal/vulvar sores or change in color | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Vaginal/vulvar sores or change in color | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HPV | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pap smear | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | !STI Panel | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Coagulation studies | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 1 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 1 | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 2 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 2 | ||
Line 77: | Line 78: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 103: | Line 105: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 134: | Line 137: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 160: | Line 164: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 186: | Line 191: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 212: | Line 218: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 238: | Line 245: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 264: | Line 272: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 289: | Line 298: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 314: | Line 324: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 339: | Line 350: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 364: | Line 376: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 389: | Line 402: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 414: | Line 428: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 439: | Line 454: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 19:36, 24 January 2019
Cervical cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cervical cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Cervical cancer differential diagnosis |
Risk calculators and risk factors for Cervical cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
Cervical cancer must be differentiated from other diseases that cause abnormal vaginal bleeding, such as cervical polyp, cervical leiomyoma, invasion of the cervix from primary uterine malignancy, vaginal cancer, cervical lymphoma, metastases to cervix, and cervical ectopic pregnancy.
Cervical cancer differential diagnosis
- Cervical cancer must be differentiated from a mass involving the cervix, and causing abnormal vaginal bleeding:
- Cervical polyp
- Cervical leiomyoma
- Cervical lymphoma
- Cervical sarcoma
- Metastases to the cervix
- Cervical ectopic pregnancy
- Cervical polyp
- Cervicitis
- Cervical erosion ( Ectropion )
- IUD use
- Pelvic inflammatory disease
- Endometriosis
- Adenomyosis
- Postcoital bleeding
- Clear cell adenocarcinoma
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical exam | Lab Findings | Imaging | Histopathology | ||||||||||||||||||||||||||
Prolonged menstrual bleeding | Heavy menstrual bleeding | Postcoital bleeding | Premenopausal bleeding | Postmenopausal bleeding | Intermenstrual bleeding | Abnormal vaginal dyscharge | Pelvic pain or pressure | Itching or burning of the vulva | Abdominal pain | Weight loss | Vaginal/vulvar sores or change in color | HPV | Pap smear | STI Panel | Coagulation studies | Imaging 1 | Imaging 2 | Imaging 3 | ||||||||||||
Cervical cancer | ||||||||||||||||||||||||||||||
Cervical polyp | ||||||||||||||||||||||||||||||
Cervical leiomyoma | ||||||||||||||||||||||||||||||
Cervical lymphoma | ||||||||||||||||||||||||||||||
Cervical sarcoma | ||||||||||||||||||||||||||||||
Cervical erosion(Ectropion) | ||||||||||||||||||||||||||||||
Cervicitis | ||||||||||||||||||||||||||||||
IUD use | ||||||||||||||||||||||||||||||
Pelvic inflammatory diseases | ||||||||||||||||||||||||||||||
Endometriosis | ||||||||||||||||||||||||||||||
Adnemyosis | ||||||||||||||||||||||||||||||
Postcoital bleeding | ||||||||||||||||||||||||||||||
DES exposure (Clear cell adenocarcinoma) | ||||||||||||||||||||||||||||||
Paget's disease of vulva | ||||||||||||||||||||||||||||||
Vaginal cancer |